Vaughan Nelson Investment Management L.P. Increases Holdings in Agilent Technologies, Inc. $A

Vaughan Nelson Investment Management L.P. grew its holdings in Agilent Technologies, Inc. (NYSE:AFree Report) by 25.2% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 181,992 shares of the medical research company’s stock after acquiring an additional 36,600 shares during the quarter. Vaughan Nelson Investment Management L.P. owned about 0.06% of Agilent Technologies worth $23,359,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the business. SeaBridge Investment Advisors LLC purchased a new stake in shares of Agilent Technologies during the 3rd quarter worth approximately $209,000. Kathmere Capital Management LLC purchased a new stake in Agilent Technologies in the third quarter valued at $231,000. Eads & Heald Wealth Management purchased a new stake in Agilent Technologies in the third quarter valued at $212,000. Robeco Institutional Asset Management B.V. boosted its stake in Agilent Technologies by 35.7% in the third quarter. Robeco Institutional Asset Management B.V. now owns 100,952 shares of the medical research company’s stock valued at $12,957,000 after acquiring an additional 26,573 shares in the last quarter. Finally, D.A. Davidson & CO. grew its holdings in shares of Agilent Technologies by 16.5% during the third quarter. D.A. Davidson & CO. now owns 5,280 shares of the medical research company’s stock worth $678,000 after purchasing an additional 748 shares during the last quarter.

Analyst Ratings Changes

A number of brokerages recently issued reports on A. JPMorgan Chase & Co. upped their target price on Agilent Technologies from $165.00 to $180.00 and gave the company an “overweight” rating in a research report on Tuesday, November 25th. UBS Group increased their price objective on Agilent Technologies from $170.00 to $180.00 and gave the company a “buy” rating in a report on Tuesday, November 25th. Rothschild & Co Redburn started coverage on shares of Agilent Technologies in a report on Wednesday, October 8th. They issued a “buy” rating and a $165.00 target price on the stock. Morgan Stanley assumed coverage on shares of Agilent Technologies in a research report on Tuesday, December 2nd. They issued an “overweight” rating for the company. Finally, Wells Fargo & Company raised their price objective on shares of Agilent Technologies from $150.00 to $175.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 25th. One analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $163.31.

View Our Latest Stock Analysis on Agilent Technologies

Agilent Technologies Price Performance

Shares of NYSE:A opened at $147.81 on Thursday. Agilent Technologies, Inc. has a 52 week low of $96.43 and a 52 week high of $160.27. The company has a 50-day moving average price of $144.46 and a 200 day moving average price of $132.13. The company has a market cap of $41.90 billion, a P/E ratio of 32.34, a PEG ratio of 4.29 and a beta of 1.29. The company has a quick ratio of 1.52, a current ratio of 1.96 and a debt-to-equity ratio of 0.45.

Agilent Technologies (NYSE:AGet Free Report) last posted its quarterly earnings results on Monday, November 24th. The medical research company reported $1.59 EPS for the quarter, beating the consensus estimate of $1.58 by $0.01. Agilent Technologies had a return on equity of 25.20% and a net margin of 18.75%.The business had revenue of $1.86 billion during the quarter, compared to analysts’ expectations of $1.83 billion. During the same period last year, the firm earned $1.46 EPS. The company’s quarterly revenue was up 9.4% compared to the same quarter last year. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. Research analysts predict that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 28th. Investors of record on Tuesday, January 6th will be issued a $0.255 dividend. The ex-dividend date is Tuesday, January 6th. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.7%. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.25. Agilent Technologies’s payout ratio is currently 22.32%.

Insider Buying and Selling at Agilent Technologies

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 12,490 shares of the company’s stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $150.00, for a total value of $1,873,500.00. Following the sale, the chief executive officer owned 33,448 shares of the company’s stock, valued at approximately $5,017,200. This represents a 27.19% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Rodney Gonsalves sold 3,000 shares of Agilent Technologies stock in a transaction that occurred on Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total value of $464,970.00. Following the transaction, the vice president owned 31,846 shares of the company’s stock, valued at $4,935,811.54. This represents a 8.61% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 16,401 shares of company stock valued at $2,468,962.

Agilent Technologies Company Profile

(Free Report)

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Featured Stories

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:AFree Report).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.